Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RACECADOTRIL Cause Toxic epidermal necrolysis? 83 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Toxic epidermal necrolysis have been filed in association with RACECADOTRIL. This represents 11.4% of all adverse event reports for RACECADOTRIL.

83
Reports of Toxic epidermal necrolysis with RACECADOTRIL
11.4%
of all RACECADOTRIL reports
72
Deaths
68
Hospitalizations

How Dangerous Is Toxic epidermal necrolysis From RACECADOTRIL?

Of the 83 reports, 72 (86.7%) resulted in death, 68 (81.9%) required hospitalization, and 50 (60.2%) were considered life-threatening.

Is Toxic epidermal necrolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RACECADOTRIL. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does RACECADOTRIL Cause?

Acute kidney injury (80) Rash maculo-papular (69) Confusional state (55) Drug reaction with eosinophilia and systemic symptoms (49) Eosinophilia (49) Thrombocytopenia (41) Hepatocellular injury (39) Somnolence (37) Off label use (32) Vomiting (29)

What Other Drugs Cause Toxic epidermal necrolysis?

ACETAMINOPHEN (980) LAMOTRIGINE (941) ALLOPURINOL (858) IBUPROFEN (764) SULFAMETHOXAZOLE\TRIMETHOPRIM (592) CIPROFLOXACIN (576) FUROSEMIDE (521) VANCOMYCIN (515) PIPERACILLIN\TAZOBACTAM (490) PEMBROLIZUMAB (444)

Which RACECADOTRIL Alternatives Have Lower Toxic epidermal necrolysis Risk?

RACECADOTRIL vs RADIATION THERAPY RACECADOTRIL vs RADIUM RA-223 DICHLORIDE RACECADOTRIL vs RALOXIFENE RACECADOTRIL vs RALTEGRAVIR RACECADOTRIL vs RALTITREXED

Related Pages

RACECADOTRIL Full Profile All Toxic epidermal necrolysis Reports All Drugs Causing Toxic epidermal necrolysis RACECADOTRIL Demographics